Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06066710 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Propranolol in Primary Progressive Aphasia

StatusRecruiting
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Site contact updatedv7
  2. Start date changed from estimate of Mar 2025 to Jan 13, 2025v6
  3. Enrollment target: 20 to 30v5 Show 4 more changesShow less
    • Start date: Oct 2024 to Mar 2025
    • Primary completion date: Oct 2026 to Dec 2026
    • Study completion date: Oct 2026 to Dec 2027
    • Site contact updated
  4. Start date: May 2024 to Oct 2024v4
  5. Start date: Jan 2024 to May 2024v3
  6. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Nov 2023 to Jan 2024
    • Site details revised
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to find out how the language of people with Primary Progressive Aphasia is affected by Propranolol. Propranolol is not FDA approved for the treatment of Primary Progressive Aphasia. Propranolol is FDA approved for the treatment of heart conditions such as blood pressure. This research is being done because there are currently no drug treatment options for language impairments and anxiety often experienced by people with Primary Progressive Aphasia.
Trial Details
NCT Number NCT06066710
Lead Sponsor University of Missouri-Columbia
Conditions
(from sponsor)		 Aphasia, Primary Progressive
Related terms Aphasia, Primary Progressive
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov